Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Congo's fast-moving Ebola outbreak becomes country's worst with over 2,300 dead

BUNIA, Congo — Congo’s fast-moving Ebola outbreak has now killed over 2,300 people and become the deadliest outbreak of the disease on record in the Central African nation. The outbreak unfolding in one of Congo’s most vulnerable regions is the fastest-growing Ebola outbreak ever, with 4,945 cases including 2,325 deaths, according to government data released overnight into Monday. It's Congo’s…

Congo's fast-moving Ebola outbreak becomes country's worst with over 2,300 dead

BUNIA, Congo — The Ebola outbreak in Congo has now claimed over 2,300 lives, making it the deadliest outbreak in the history of the disease in the Central African nation. Unfolding in one of Congo's most vulnerable regions, this outbreak is the fastest-growing on record, with 4,945 confirmed cases resulting in 2,325 deaths, according to government data released overnight into Monday.

This marks Congo's 17th Ebola outbreak, surpassing the toll of the 2018-2020 outbreak, which recorded 2,299 deaths out of 3,481 cases. As of the latest data, 101 new cases and 33 deaths were reported within the previous 24 hours. Despite over 1,000 recoveries, 730 individuals remain hospitalized or in isolation. The outbreak's rapid progression has alarmed health authorities, with the World Health Organization fearing it may outpace the 2014-16 West African Ebola outbreak, the deadliest with over 11,000 deaths.

Trish Newport, the emergency coordinator for Doctors Without Borders (MSF), highlighted the challenge of community engagement amidst the crisis.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at koreatimes.co.kr →

More in Health & Medicine

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Candidate

JW Pharmaceutical has moved a step closer to developing a next-generation obesity treatment with a less frequent dosing schedule.The company said Tuesday that it has submitted an Investigational New…

  • JW Pharmaceutical files for Phase 3 trial of bofanglutide in South Korea.
  • 300 obese adults to enroll in Korean trial beginning December.
  • Biweekly dosing could reduce injections from 52 to 26 per year.

Celltrion Completes Integration of France’s Gifrer, Steps Up European Pharmacy Strategy Subtitle

Celltrion has completed the post-acquisition integration of French healthcare company Gifrer, paving the way for a full-scale expansion of its pharmacy business across Europe.Celltrion Chairman Seo…

  • Celltrion completed integration of French pharma company Gifrer.
  • Gifrer operates 9,000+ pharmacies and supplies to 800+ hospitals.
  • Celltrion aims to boost European pharmacy sales for SC biosimilars.

More from Tuesday 18 August →